• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 85 Day 1 on August 20; Register to live stream

    8/19/25 7:00:00 AM ET
    $ADVM
    $CLNN
    $DERM
    $EHGO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    MIAMI, Aug. 19, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 85th Emerging Growth Conference on August 20 & 21, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com

    For updates, follow us on Twitter.

    Day 1

    August 20, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Immuron Limited (NASDAQ:IMRN)

    Keynote speaker: Steve Lydeamore, CEO

    9:40 – 10:10

    Nutriband, Inc. (NASDAQ:NTRB)

    Keynote speaker: Serguei Melnik, Founder and President

    10:50 – 11:20

    Metaguest.ai Inc. (OTCQB:MGSTF) (CSE:METG)

    Keynote speaker: Colin Keddy, President

    11:25 – 11:55

    Kelly+Partners (OTCQX:KPGHF) (ASX: KPG)

    Keynote speaker: Brett Kelly, Founder, Executive Chairman & CEO

    12:35 – 1:05

    Journey Medical Corporation (NASDAQ:DERM)

    Keynote speaker: Claude Maraoui - Founder, President, CEO & Director

    1:10 – 1:40

    22nd Century Group, Inc. (NASDAQ:XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    1:45 – 2:15

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:20 – 2:50

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    2:55 – 3:05

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    3:10 – 3:20

    HeartSciences, Inc. (NASDAQ:HSCS)

    Keynote speaker: Andrew Simpson, President / CEO

    Postponed to September 24

    Adverum Biotechnologies (NASDAQ:ADVM)

    Keynote speaker: Jason Awe, PhD, MBA, Corporate Communications & IR

    3:40 – 3:50

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    3:55 – 4:05

    BitFuFu Inc. (NASDAQ:FUFU)

    Keynote speaker: Charley Brady, VP Investor Relations

    4:10 – 4:20

    Impact Minerals Limited, (ASX: IPT)

    Keynote speaker: Dr. Mike Jones, Managing Director

    4:25 – 4:35

    Zyppah, a Private Company

    Keynote speaker: Dr. Jonathan Greenburg, founder and owner, & Larry Biggs, CEO

    4:40 – 4:50

    Ucore Rare Metals, Inc. (OTCQX:UURAF) (TSXV:UCU)

    Keynote speakers: Pat Ryan, CEO

    ____________________

    Day 2

    August 21, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    Eshallgo, Inc. (NASDAQ:EHGO)

    Keynote speakers: Johnny Wu, President

    10:15 – 10:45

    Terra Clean Energy (OTCQB:TCEFF) (CSE:TCEC)

    Keynote speaker: Greg Cameron, CEO

    10:50 – 11:20

    Grove Collaborative Holdings, Inc. (NYSE:GROV)

    Keynote speakers: Jeff Yurcisin, CEO & Tom Siragusa, Interim CEO

    11:25 – 11:55

    Phoenix Energy Services Corp., (OTCQB:PHXHF) (TSE: PHX)

    Keynote speaker: Mike Buker, President and CEO

    12:00 – 12:30

    Vista Gold Corp. (NYSE:VGZ) (TSX:VGZ)

    Keynote speaker: Frederick Earnest, CEO

    12:35 – 1:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden – VP Corporate Development

    1:10 – 1:40

    Kobo Resources, Inc. (OTCQB:KBRIF) (TSXV:KRI)

    Keynote speakers: Edouard Gosselin, Director, CEO and Corporate Secretary & Paul Sarjeant, Director, President and COO

    1:45 – 2:15

    Puma Exploration Inc. (TSXV:PUMA) (OTCQB:PUMXF)

    Marcel Robillard, CEO & President

    2:20 – 2:50

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    2:55 – 3:05

    Highland Copper Company Inc. (OTCQB:HDRSF) (TSXV:HI)

    Keynote speaker: Barry O'Shea, CEO

    3:10 - 3:20

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    3:25 – 3:35

    C3 Metals Inc. (TSXV:CCCM) (OTCQB:CUAUF)

    Keynote speaker: Daniel A. Symons, President, CEO & Director

    3:40 – 3:50

    Lahontan Gold Corp. (TSXV:LG) (OTCQB:LGCXF)

    Keynote speaker: Kimberly Ann, President / CEO

    3:55 – 4:05

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    4:10 – 4:20

    Vizsla Royalties Corp. (TSXV:VROY) (OTCQB:VROYF)

    Keynote speaker: Michael N. Pettingell, President and CEO

    4:25 – 4:35

    Star Gold Corp. (OTCQB:SRGZ)

    Keynote speaker: Lindsay E. Gorrill, Chairman & CEO

    4:40 – 4:50

    NCS Multistage Holdings, Inc. (NASDAQ:NCSM)

    Keynote speaker: Ryan Hummer, CEO & Director

    Register for the Conference here.

    Submit Questions for any of the presenting companies to: Questions@EmergingGrowth.com

    Replays: Subscribe to our YouTube Channel.

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients.  Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future.  In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: Conference@EmergingGrowth.com



    Primary Logo

    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $CLNN
    $DERM
    $EHGO

    CompanyDatePrice TargetRatingAnalyst
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Adverum Biotechnologies Inc.
    $ADVM
    11/17/2025Buy → Neutral
    H.C. Wainwright
    Journey Medical Corporation
    $DERM
    8/25/2025$13.00Buy
    H.C. Wainwright
    BitFuFu Inc.
    $FUFU
    8/13/2025$6.00Buy
    Roth Capital
    Journey Medical Corporation
    $DERM
    7/30/2025$12.00Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    7/18/2025Buy
    B. Riley Securities
    BitFuFu Inc.
    $FUFU
    6/18/2025$5.50Market Perform
    Northland Capital
    Grove Collaborative Holdings Inc.
    $GROV
    5/15/2025$1.20Outperform → Market Perform
    Telsey Advisory Group
    More analyst ratings

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Adverum Biotech downgraded by H.C. Wainwright

    H.C. Wainwright downgraded Adverum Biotech from Buy to Neutral

    11/17/25 9:39:07 AM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    H.C. Wainwright initiated coverage on Journey Medical with a new price target

    H.C. Wainwright initiated coverage of Journey Medical with a rating of Buy and set a new price target of $13.00

    8/25/25 8:12:40 AM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Weatherford Announces Second Quarter 2026 Results

    Second quarter revenue of $1,105 million decreased 4% sequentially  Second quarter operating income of $107 million decreased 13% sequentiallySecond quarter net income of $39 million decreased 64% sequentially; net income margin of 3.5%Second quarter adjusted EBITDA* of $223 million, decreased 4% sequentially; adjusted EBITDA margin* of 20.2% decreased 4 basis points sequentiallySecond quarter cash provided by operating activities of $175 million and adjusted free cash flow* of $139 millionShareholder return of $36 million for the quarter, which included dividend payments of $20 million and share repurchases of $16 millionAnnounced the acquisition of NCS Multistage (NASDAQ:NCSM) in a stock-a

    7/21/26 4:30:00 PM ET
    $WFRD
    $NCSM
    Oil and Gas Field Machinery
    Consumer Discretionary
    Oilfield Services/Equipment
    Energy

    Immuron CEO, Steven Lydeamore presentation at Kalkine Media Webinar

    MELBOURNE, Australia, July 20, 2026 (GLOBE NEWSWIRE) -- Immuron Limited ((ASX: IMC, NASDAQ:IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore is presenting virtually at the Kalkine Media Webinar on Monday, 20th July 2026 (12:30pm Australian Eastern Time). A copy of the presentation slide deck is available on the Company’s website: https://investors.immuron.com.au/announcements/7639968 This release has been authorised by the directors of Immuron Limited. COMPANY CONTACT:Steven LydeamoreChief Executive Officersteve@immuron.com           About ImmuronImmuron Limited ((ASX: IMC, NASDAQ:IMRN), is an Australian biopharmaceutical company focused on developing and commerci

    7/20/26 6:00:00 AM ET
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    22nd Century Group (Nasdaq: XXII) Appoints Katherine Rouse-Bailey as Vice President of Marketing

    XXII investing in expanded marketing initiatives to drive VLN® brand awareness and growth MOCKSVILLE, N.C., July 16, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced the appointment of Katherine Rouse-Bailey as Vice President of Marketing. The enhanced marketing initiatives are designed to strengthen brand awareness, increase consumer trial and support retail sell-through across the Company’s growing commercial footprint. "We are sharpening our focus on marketing and VLN® cigarette brand awareness to drive trial and support repeat purchase," said Larry Firestone

    7/16/26 9:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Officer Watson Danielle

    4 - HeartSciences Inc. (0001468492) (Issuer)

    7/9/26 9:30:02 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    Director Toledano Miranda Jayne was granted 50,000 shares, increasing direct ownership by 42% to 168,618 units (SEC Form 4)

    4 - Journey Medical Corp (0001867066) (Issuer)

    7/2/26 4:07:30 PM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Smith Justin Adam was granted 50,000 shares, increasing direct ownership by 28% to 231,618 units (SEC Form 4)

    4 - Journey Medical Corp (0001867066) (Issuer)

    7/2/26 4:06:26 PM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CEO, PRESIDENT AND DIRECTOR Fischer Laurent bought $553,917 worth of shares (128,699 units at $4.30), increasing direct ownership by 177% to 201,513 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:06 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    CHIEF OPERATING OFFICER Soparkar Peter bought $211,000 worth of shares (50,000 units at $4.22), increasing direct ownership by 166% to 80,189 units (SEC Form 4)

    4 - Adverum Biotechnologies, Inc. (0001501756) (Issuer)

    12/8/25 9:45:04 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    SEC Filings

    View All

    SEC Form 6-K filed by Immuron Limited

    6-K - Immuron Ltd (0001660046) (Filer)

    7/20/26 9:37:41 PM ET
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Immuron Limited

    6-K - Immuron Ltd (0001660046) (Filer)

    7/20/26 8:00:19 AM ET
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Immuron Limited

    6-K - Immuron Ltd (0001660046) (Filer)

    7/15/26 9:28:55 PM ET
    $IMRN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Leadership Updates

    Live Leadership Updates

    View All

    22nd Century Group (Nasdaq: XXII) Appoints Katherine Rouse-Bailey as Vice President of Marketing

    XXII investing in expanded marketing initiatives to drive VLN® brand awareness and growth MOCKSVILLE, N.C., July 16, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced the appointment of Katherine Rouse-Bailey as Vice President of Marketing. The enhanced marketing initiatives are designed to strengthen brand awareness, increase consumer trial and support retail sell-through across the Company’s growing commercial footprint. "We are sharpening our focus on marketing and VLN® cigarette brand awareness to drive trial and support repeat purchase," said Larry Firestone

    7/16/26 9:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Vista Gold Strengthens the Mt Todd Project Execution Team with the Appointment of Julie Jones as General Counsel and Company Secretary and Advances Search for a Managing Director

    Vista Gold Corp. (NYSE American and TSX:VGZ) is pleased to announce the appointment of Julie Jones as General Counsel and Company Secretary of Vista Gold Australia Pty Ltd. Ms. Jones will be based in the Company's Perth office and will play an important role in establishing the Mt Todd gold project as a leading gold producer in Northern Territory, Australia. The appointment reflects Vista's continued focus on strengthening its executive project execution capabilities as the Company advances Mt Todd, one of the largest undeveloped gold projects in Australia. Ms. Jones brings more than 20 years of legal and executive leadership experience across ASX100 companies, global mining operators, an

    5/13/26 5:01:00 PM ET
    $VGZ
    Precious Metals
    Basic Materials

    Cinch Home Services Welcomes Digital Transformation Leader Kristine Miller to its Board of Advisors

    BOCA RATON, Fla., Jan. 22, 2026 /PRNewswire/ -- Cinch Home Services today announced the appointment of Kristine (Kris) Miller to its Board of Advisors. Miller is a highly regarded digital, strategy, and transformation leader with more than two decades of experience helping organizations modernize, scale, and deliver customer-centered growth across complex, consumer-facing businesses. As a member of the Board, she will help guide Cinch Home Services' strategic direction as the company continues to expand its mission of simplifying home ownership through innovative and reliable home protection solutions. 

    1/22/26 1:00:00 PM ET
    $GROV
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Financials

    Live finance-specific insights

    View All

    Weatherford Announces Second Quarter 2026 Results

    Second quarter revenue of $1,105 million decreased 4% sequentially  Second quarter operating income of $107 million decreased 13% sequentiallySecond quarter net income of $39 million decreased 64% sequentially; net income margin of 3.5%Second quarter adjusted EBITDA* of $223 million, decreased 4% sequentially; adjusted EBITDA margin* of 20.2% decreased 4 basis points sequentiallySecond quarter cash provided by operating activities of $175 million and adjusted free cash flow* of $139 millionShareholder return of $36 million for the quarter, which included dividend payments of $20 million and share repurchases of $16 millionAnnounced the acquisition of NCS Multistage (NASDAQ:NCSM) in a stock-a

    7/21/26 4:30:00 PM ET
    $WFRD
    $NCSM
    Oil and Gas Field Machinery
    Consumer Discretionary
    Oilfield Services/Equipment
    Energy

    Fortitude and HeartSciences (Nasdaq: HSCS) Announce Business Combination, Aiming to Bring a Leading Vertically-Integrated Zcash Mining Platform to the Public Markets

    Combined company expected to operate under the Fortitude brand and to trade on Nasdaq under the ticker symbol "TUDE"; transaction expected to close in H2 2026 Upon completion of the transaction, Fortitude believes it will be the first publicly traded venture mining platform with a track record of identifying high-conviction, early-stage Proof-of-Work opportunities Fortitude Mining Holdings, Inc. ("Fortitude"), a vertically-integrated digital asset mining platform anchored in Zcash, and HeartSciences Inc. (NASDAQ:HSCS) ("HeartSciences"), an AI-powered medical technology company, today announced that they have entered into a definitive merger agreement to combine in an all-stock transacti

    6/23/26 7:30:00 AM ET
    $HSCS
    Industrial Specialties
    Health Care

    BitFuFu Reports Unaudited First Quarter 2026 Financial Results

    SINGAPORE, May 29, 2026 (GLOBE NEWSWIRE) -- BitFuFu Inc. ("BitFuFu" or the "Company") (NASDAQ:FUFU), a world-leading Bitcoin miner and mining services innovator, today announced its unaudited financial results for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights Total revenue was $72.7 million, a decrease of 6.8% from $78.0 million in the same period of 2025.     Three Months Ended March 31,   2026  2025 Category ($ in millions) Revenue % ofRevenue  Revenue % ofRevenue Cloud Mining Solutions $57.5  79.1% $53.7  68.8%Self-Mining Operations  11.4  15.7%  17.6  22.6%Mining Equipment Sales  -  0.0%  6.0  7.7%Hosting Revenue and Others  3.8  5.2%  0.7  0.9%Total Reven

    5/29/26 6:00:00 AM ET
    $FUFU
    Finance: Consumer Services
    Finance

    $ADVM
    $CLNN
    $DERM
    $EHGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Journey Medical Corporation

    SC 13G - Journey Medical Corp (0001867066) (Subject)

    11/29/24 2:00:25 PM ET
    $DERM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Adverum Biotechnologies Inc.

    SC 13G/A - Adverum Biotechnologies, Inc. (0001501756) (Subject)

    11/14/24 6:57:12 PM ET
    $ADVM
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care